Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17033266rdf:typepubmed:Citationlld:pubmed
pubmed-article:17033266lifeskim:mentionsumls-concept:C0022661lld:lifeskim
pubmed-article:17033266lifeskim:mentionsumls-concept:C0001206lld:lifeskim
pubmed-article:17033266lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:17033266lifeskim:mentionsumls-concept:C0805586lld:lifeskim
pubmed-article:17033266pubmed:issue8lld:pubmed
pubmed-article:17033266pubmed:dateCreated2006-10-11lld:pubmed
pubmed-article:17033266pubmed:abstractTextChronic renal failure is associated with an impairment of the GH/IGF-I axis. We report the diagnostic challenges in a 72-yr-old female suffering from end-stage renal disease and presenting with clinical findings suggestive of acromegaly. GH was not suppressed during an oral glucose tolerance test, but rose paradoxically. However, serum IGF-I levels were within the normal range. IGF-binding proteins (IGFBP)-2 and -3 were markedly elevated and GH-binding protein (GHBP) was diminished. Clinical findings suspicious of acromegaly could be ascribed to pre-existing characteristics and consequences of end-stage renal disease. This suggested that the disturbances of the GH/IGF-I axis in our patient were due to chronic renal disease, rather than acromegaly. In the work-up for acromegaly, clinicians should be alerted to GH resistance in chronic renal failure.lld:pubmed
pubmed-article:17033266pubmed:languageenglld:pubmed
pubmed-article:17033266pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17033266pubmed:citationSubsetIMlld:pubmed
pubmed-article:17033266pubmed:statusMEDLINElld:pubmed
pubmed-article:17033266pubmed:monthSeplld:pubmed
pubmed-article:17033266pubmed:issn1720-8386lld:pubmed
pubmed-article:17033266pubmed:authorpubmed-author:QuabbeH JHJlld:pubmed
pubmed-article:17033266pubmed:authorpubmed-author:HäringH UHUlld:pubmed
pubmed-article:17033266pubmed:authorpubmed-author:RankeM BMBlld:pubmed
pubmed-article:17033266pubmed:authorpubmed-author:GallwitzBBlld:pubmed
pubmed-article:17033266pubmed:authorpubmed-author:HorgerMMlld:pubmed
pubmed-article:17033266pubmed:authorpubmed-author:MüssigKKlld:pubmed
pubmed-article:17033266pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17033266pubmed:volume29lld:pubmed
pubmed-article:17033266pubmed:ownerNLMlld:pubmed
pubmed-article:17033266pubmed:authorsCompleteYlld:pubmed
pubmed-article:17033266pubmed:pagination745-9lld:pubmed
pubmed-article:17033266pubmed:meshHeadingpubmed-meshheading:17033266...lld:pubmed
pubmed-article:17033266pubmed:meshHeadingpubmed-meshheading:17033266...lld:pubmed
pubmed-article:17033266pubmed:meshHeadingpubmed-meshheading:17033266...lld:pubmed
pubmed-article:17033266pubmed:meshHeadingpubmed-meshheading:17033266...lld:pubmed
pubmed-article:17033266pubmed:meshHeadingpubmed-meshheading:17033266...lld:pubmed
pubmed-article:17033266pubmed:meshHeadingpubmed-meshheading:17033266...lld:pubmed
pubmed-article:17033266pubmed:year2006lld:pubmed
pubmed-article:17033266pubmed:articleTitleAcromegaly and end-stage renal disease: a diagnostic challenge.lld:pubmed
pubmed-article:17033266pubmed:affiliationDivision of Endocrinology, Metabolism, and Pathobiochemistry, Department of Internal Medicine, University Hospital of Tubingen, Tubingen, Germany. Karsten.Muessig@med.uni-tuebingen.delld:pubmed
pubmed-article:17033266pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17033266pubmed:publicationTypeCase Reportslld:pubmed